Damdinbazar, Otgonbayar
Loading...
Товч нэр
Damdinbazar, Otgonbayar
Бүтэн нэр
Damdinbazar Otgonbayar
Латин нэр
Damdinbazar Otgonbayar
Албан тушаал
Судлаач
ORCID
Scopus Author ID
2 results
Now showing 1 - 2 of 2
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, The Relationship Between Health Parameters, Body Size, Elements of Lifestyle, and Hand Grip Strength in a Group of Patients with Type 2 Diabetes, Aged 40-98, from Ulaanbaatar, Mongolia(MDPI AG, 2024-12); ; ; Background/Objectives: Decreased muscle strength and lower hand grip strength (HGS) values are observed in patients with type 2 diabetes (T2D). This study aimed to present the values of hand grip strength as a valuable tool in T2D treatment monitoring in the context of body size and lifestyle elements in 347 patients with type 2 diabetes from Ulaanbaatar, Mongolia. Methods: A retrospective cross-sectional study was performed at hospitals in Ulaanbaatar, Mongolia. The maximum grip strengths of the right and left hands were measured three times, alternatively, using a digital hand dynamometer. The maximum grip strength of the dominant hand was used for the analysis. Results: The values of HGS in both hands dropped with increased age, systolic blood pressure (SBP), the duration of diabetes, and low glucose blood levels, whereas they increased with height. Patients who smoked had the lowest three values of HGS (the average value for each hand), whereas patients who quit smoking had the highest values. Second-order interactions between diastolic blood pressure (DBP) and sex showed a significant effect on the average HGS of both hands and for the left hand in particular (where HGS decreased only in females, whereas it increased in males). Conclusions: HGS is influenced by important socioeconomic and anthropometric factors in patients with type 2 diabetes, making it a valuable indicator of general health.Scopus© Citations 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey(Elsevier BV, 2021-12); ; ; BACKGROUND: With the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020, Mongolia implemented rapid emergency measures and did not report local transmission until November 2020. We conducted a national seroprevalence survey to monitor the burden of SARS-CoV-2 in Mongolia in the months surrounding the first local transmission. METHODS: During October-December 2020, participants were randomly selected using age stratification and invited for interviews and blood samples at local primary health centres. We screened for total SARS-CoV-2 antibodies, followed by two-step quantitative SARS-CoV-2 IgG serology tests for positive samples. Weighted and test-adjusted seroprevalences were estimated. We used chi-square, Fisher's exact and other tests to identify variables associated with seropositivity. FINDINGS: A total of 5000 subjects were enrolled. We detected SARS-CoV-2 IgG antibodies in 72 samples. Crude seroprevalence of SARS-CoV-2 antibodies was 1·44% (95%CI,1·21-1·67). Population weighted and test-adjusted seroprevalences were 1·36% (95%CI,1·11-1·63) and 1·45% (95%CI,1·11-1·63), respectively. Age, sex, geographical, and occupational factors were not associated with seropositivity (p>0·05). Symptoms and signs within past 3 months and seropositivity were not associated at the time of the survey (p>0·05). INTERPRETATION: SARS-CoV-2 seroprevalence in Mongolia was low in the first year of the pandemic potentially due to strong public health measures, including border restrictions, educational facilities closure, earlier adoption of mask-wearing and others. Our findings suggest large-scale community transmission could not have occurred up to November 2020 in Mongolia. Additional serosurveys are needed to monitor the local pandemic dynamic and estimate how far from herd immunity Mongolia will be following-up with vaccination programme in 2021 and 2022. FUNDING: World Health Organisation, WHO UNITY Studies initiative, with funding by the COVID-19 Solidarity Response Fund and the German Federal Ministry of Health (BMG) COVID-19 Research and development. TRANSLATION: Cyrillic and Traditional Mongolian translation of abstract is available on appendix section.Scopus© Citations 14